565 related articles for article (PubMed ID: 10848874)
21. Gonadotropin pulsatility in Cushing's syndrome compared with polycystic ovary syndrome.
Penezić Z; Zarković M; Vujović S; Cirić J; Beleslin B; Ivović M; Pokrajac A; Drezgić M
Gynecol Endocrinol; 2005 Mar; 20(3):150-4. PubMed ID: 16019354
[TBL] [Abstract][Full Text] [Related]
22. The effects of prolonged, intracerebroventricular prolactin treatment on luteinizing hormone secretion, catecholaminergic activity and estrous behavior in ewes.
Misztal T; Romanowicz K; Tomaszewska-Zaremba D; Wójcik-Gładysz A; Barcikowski B
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):215-21. PubMed ID: 15127327
[TBL] [Abstract][Full Text] [Related]
23. The effects of intracerebroventricular infusion of prolactin in luteinizing hormone, testosterone and growth hormone secretion in male sheep.
Romanowicz K; Misztal T; Barcikowski B
Anim Reprod Sci; 2004 Apr; 81(3-4):261-71. PubMed ID: 14998652
[TBL] [Abstract][Full Text] [Related]
24. [Bromocriptine treatment of hyperprolactinemia].
Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
[TBL] [Abstract][Full Text] [Related]
25. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
26. Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women.
Genazzani AD; Petraglia F; Benatti R; Montanini V; Algeri I; Volpe A; Genazzani AR
J Clin Endocrinol Metab; 1991 Jun; 72(6):1220-5. PubMed ID: 2026744
[TBL] [Abstract][Full Text] [Related]
27. Different effects of subnormal levels of progesterone on the pulsatile and surge mode secretion of luteinizing hormone in ovariectomized goats.
Kim S; Tanaka T; Kamomae H
Biol Reprod; 2003 Jul; 69(1):141-5. PubMed ID: 12606364
[TBL] [Abstract][Full Text] [Related]
28. [Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
Pereira JL; García-Luna PP; Leal-Cerro A; Cortés A; Trujillo F; Villamil F; Vaquero F; Revuelta M; Astorga R
Med Clin (Barc); 1994 Jun; 103(2):59-64. PubMed ID: 8051973
[TBL] [Abstract][Full Text] [Related]
29. [An endocrinological study of hyperprolactinemia and its treatment (author's transl)].
Kimura T; Narita O; Suzuki M; Tomoda Y; Kuwayama A; Kageyama N
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):784-92. PubMed ID: 6787150
[TBL] [Abstract][Full Text] [Related]
30. Hypogonadism of male prolactinomas: relation to pulsatile secretion of LH.
Saitoh Y; Arita N; Hayakawa T; Onishi T; Koga M; Mori S; Mogami H
Andrologia; 1990; 22(6):519-24. PubMed ID: 2099670
[TBL] [Abstract][Full Text] [Related]
31. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
[TBL] [Abstract][Full Text] [Related]
32. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
Kremer JA; Borm G; Schellekens LA; Thomas CM; Rolland R
J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421
[TBL] [Abstract][Full Text] [Related]
33. [Luteal insufficiency as a prolactin-related disorder of the menstrual cycle].
Bohnet HG
Fortschr Med; 1980 Nov; 98(41):1618-23. PubMed ID: 6781997
[TBL] [Abstract][Full Text] [Related]
34. alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.
Klibanski A; Beitins IZ; Zervas NT; McArthur JW; Ridgway EC
J Clin Endocrinol Metab; 1983 Apr; 56(4):774-80. PubMed ID: 6187760
[TBL] [Abstract][Full Text] [Related]
35. Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
Hajder M; Hajder E; Dervisefendic M; Samardzic R; Alic E
Med Arch; 2013; 67(3):181-4. PubMed ID: 23848038
[TBL] [Abstract][Full Text] [Related]
36. Transient hyperprolactinemia in infertile women with luteal phase deficiency.
Huang KE; Bonfiglio TA; Muechler EK
Obstet Gynecol; 1991 Oct; 78(4):651-5. PubMed ID: 1923170
[TBL] [Abstract][Full Text] [Related]
37. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
[TBL] [Abstract][Full Text] [Related]
38. [Effects of bromocriptine on endocrine environment in the polycystic ovary syndrome].
Huang HJ; Ishimaru T; Yamabe T
Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):265-78. PubMed ID: 3136040
[TBL] [Abstract][Full Text] [Related]
39. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME; Alborzi S; Jahromi BN
Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
[TBL] [Abstract][Full Text] [Related]
40. LH/FSH ratio: a better marker of secondary amenorrhea in patients from eastern Nepal.
Lamsal M; Pokhrel S; Mahato RV; Baral N; Upreti D; Sridhar MG
Nepal Med Coll J; 2007 Sep; 9(3):147-53. PubMed ID: 18092428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
